BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8297899)

  • 1. Role of major histocompatibility complex class I alpha 1/alpha 2 domain polymorphism and in vivo expression pattern in tumor resistance: studies with transgenic mice and lymphoma cell transfectants.
    Höglund P; Waldenström M; Kärre K
    J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):175-81. PubMed ID: 8297899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains.
    Sentman CL; Olsson MY; Salcedo M; Höglund P; Lendahl U; Käre K
    J Immunol; 1994 Dec; 153(12):5482-90. PubMed ID: 7989750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of glycosylphosphatidylinositol-linked H-2Dd molecules on target cell protection and natural killer cell specificity in transgenic mice.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    Eur J Immunol; 1996 Sep; 26(9):2127-32. PubMed ID: 8814257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A.
    Olsson-Alheim MY; Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1999 Jun; 162(12):7010-4. PubMed ID: 10358142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
    Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM
    J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld.
    Milisauskas VK; Nakamura I
    Eur J Immunol; 1994 Feb; 24(2):336-42. PubMed ID: 8299682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells.
    Yu YY; Forman J; Aldrich C; Blazar B; Flaherty L; Kumar V; Bennett M
    Int Immunol; 1994 Sep; 6(9):1297-306. PubMed ID: 7529556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
    Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
    J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants.
    McCluskey J; Boyd L; Foo M; Forman J; Margulies DH; Bluestone JA
    J Immunol; 1986 Dec; 137(12):3881-90. PubMed ID: 2431046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cell receptor calibration: effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells.
    Olsson-Alheim MY; Salcedo M; Ljunggren HG; Kärre K; Sentman CL
    J Immunol; 1997 Oct; 159(7):3189-94. PubMed ID: 9317116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2.
    Crumpacker DB; Alexander J; Cresswell P; Engelhard VH
    J Immunol; 1992 May; 148(10):3004-11. PubMed ID: 1374446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells.
    Kåse A; Johansson MH; Olsson-Alheim MY; Kärre K; Höglund P
    J Immunol; 1998 Dec; 161(11):6133-8. PubMed ID: 9834098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha2 domain of H-2Dd restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A.
    Sundbäck J; Nakamura MC; Waldenström M; Niemi EC; Seaman WE; Ryan JC; Kärre K
    J Immunol; 1998 Jun; 160(12):5971-8. PubMed ID: 9637511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice.
    Salcedo M; Diehl AD; Olsson-Alheim MY; Sundbäck J; Van Kaer L; Kärre K; Ljunggren HG
    J Immunol; 1997 Apr; 158(7):3174-80. PubMed ID: 9120271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.
    Newberg MH; Smith DH; Haertel SB; Vining DR; Lacy E; Engelhard VH
    J Immunol; 1996 Apr; 156(7):2473-80. PubMed ID: 8786307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.